Scientists question ‘strange’ data in Russian coronavirus vaccine trial after ‘unlikely’ patterns

Advertisement

BEGIN ARTICLE PREVIEW:

An employee at work at the Gamaleya Scientific Research Institute of Epidemiology and Microbiology of the Russian Healthcare Ministry that produces a COVID-19 vaccine.Vyacheslav Prokofyev | TASS | Getty ImagesLONDON — A group of scientists have questioned the reliability of data published by Russian epidemiologists on early clinical trials of its “Sputnik V” coronavirus vaccine, with one telling CNBC that Russia needs to explain and clarify its results.In an open letter to the editor of The Lancet medical journal, in which Russia’s Gamaleya Research Institute of Epidemiology and Microbiology published early-stage trial results of its coronavirus vaccine last Friday, a group of scientists said the data was incomplete and had shown some “unlikely patterns.”They said the results showed that groups of participants had reported identical antibody levels at different points in the study. There are 27 signatories of the letter so far — predominantly scientists based in Europe but also including several in the U.S. and Asia.”There are several data patterns which appear repeatedly for the reported experiments,” the open letter said. “On the ground of simple probabilistic evaluations the fact of observing so many data points preserved among different experiments is highly unlikely.”The scientists were also concerned at …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE